Overview
This study quantifies total mercury in 60 skin-lightening products purchased from 12 vendors across Jamaica (February–May 2017) and surveys 384 users about application patterns. The analytical strategy is two-stage: portable handheld energy-dispersive X-ray fluorescence (XRF) on all 60 products for primary screening, with cold-vapor atomic absorption spectroscopy (CVAAS) on a 25-sample subset whose XRF readings fell below the XRF detection limit. Six of 60 products exceeded the US FDA 1 ppm limit for mercury in cosmetics; three products carried “alarmingly high” concentrations above 400 ppm. The XRF range across the full panel spanned 0.05 ppm to 17,547 ppm — five orders of magnitude. The CVAAS sub-panel (excluded by design from the higher-concentration products) ranged 0.05 ppm to 3.68 ppm. Cream formulations carried the highest mean mercury content in the CVAAS sub-panel; soap, lotion, and “other” formulations were lower. The survey component documents that 51% of female users and 49% of male users apply skin-lightening products more than once per day, and that combining multiple products in homemade mixtures is common.
Key numbers
Full panel of 60 skin-lightening products purchased in Jamaica, Feb–May 2017 — XRF screening (Niton XL3T GOLDD+ handheld; detection limit ≈10 ppm mercury (Hg) in the cream/soap matrix as calibrated):
| Statistic | Hg (ppm) |
|---|---|
| Minimum across 60 products | 0.05 |
| Maximum across 60 products | 17,547 |
| Products above 10 ppm (XRF DL) | 3 of 60 |
| Products above 400 ppm (“alarmingly high”) | 3 of 60 |
| Products above the US FDA 1 ppm cosmetic limit | 6 of 60 |
| Products below 10 ppm | 57 of 60 (95%) |
CVAAS sub-panel of 25 products (Buck Scientific 400A; detection limit 0.03 µg/g = 30 ppb Hg). This sub-panel was drawn from the 57 products whose XRF screen was below the XRF detection limit; the three highest-XRF products are not represented here.
CVAAS quartile breakdown (source Table 3):
| Quartile | n | Mean ± SD (ppm) | Range (ppm) |
|---|---|---|---|
| Q1 (lowest) | 9 | 0.06 ± 0.02 | 0.05 – 0.10 |
| Q2 | 5 | 0.14 ± 0.02 | 0.12 – 0.16 |
| Q3 | 5 | 0.24 ± 0.05 | 0.18 – 0.29 |
| Q4 (highest) | 6 | 1.41 ± 1.3 | 0.33 – 3.68 |
| Full sub-panel | 25 | — | 0.05 – 3.68 |
CVAAS sub-panel split by product formulation (source Table 4):
| Formulation | n | Mean ± SD (ppm) | Range (ppm) |
|---|---|---|---|
| Soap | 7 | 0.18 ± 0.11 | 0.05 – 0.45 |
| Cream | 14 | 0.67 ± 1.04 | 0.05 – 3.68 |
| Lotion | 2 | 0.11 ± 0.01 | 0.08 – 0.12 |
| Other (skin-lightening oil and pills) | 2 | 0.05 ± 0.01 | 0.05 – 0.06 |
Country of manufacture of skin-lightening products encountered on the Jamaican market (source Table 2; reported n = 109, but the eight tabulated counts sum to 100 — see Verification notes):
| Country | Count |
|---|---|
| Ivory Coast | 19 |
| European Union | 19 |
| Lebanon | 15 |
| United States | 15 |
| England | 10 |
| Jamaica | 8 |
| India | 8 |
| Other | 6 |
The authors note that some products originating from European nations and the Ivory Coast had mercury concentrations greater than 1 ppm.
User survey (n = 384 self-identified users of skin-lightening products in Jamaica):
- Sex: 196 female (51%); 188 male (49%)
- Age: 280 <30 yr; 92 31–50 yr; 12 >50 yr
- Frequency of application: 197 more than once per day; 130 once per day; 57 once per week
- Socioeconomic: 192 employed; 84 unemployed; 108 student
- Mixing of products: 221 of 384 (58%) reported combining different skin-lightening products in homemade mixtures
- Reported health effects: itchiness 55; irritability 52; “other” (headaches, scars, depression) 31 — total 138 reports of side effects, of which 79 were among individuals using a product with Hg above 1 ppm. Of 30 individuals reporting headaches, scars, or depression, 93% used a product containing more than 1 ppm mercury.
Cross-country context cited by the authors (source Table 5; not measured in this study — reproduced as the authors’ literature comparator):
| Country | Hg concentration range across cited studies (ppm) |
|---|---|
| Jamaica (present study) | 0.05 – 17,345.00 |
| Ghana | 0.006 – 0.549 |
| Malaysia | 0.00 – 1.13 |
| India | 0.14 – 0.36 |
| Mexico | 878.00 – 36,000.00 |
| China | 0.00 – 0.59 |
| United States | 1,729.00 – 45,622.00 |
| West Africa | 0.00005 – 0.27 |
Regulatory anchors as cited within the source:
- US FDA: <1 ppm mercury in skin-lightening cosmetics (the binding action level the authors compare against)
- European Union and many African nations: outright bans on mercury in cosmetics
- Minamata Convention Articles 4, 16, 17, 18 and Annex A of Article 3: cited by the authors as the international framework this study supports
Contextual case report cited by the authors (Al-Saleh 2016, ref. 9 of the source; not measured in this study): A Belgian woman who used a 1%-mercury skin-lightening soap during pregnancy and lactation recorded blood Hg 91 µg/L and urine Hg 784 µg/g; her three-month-old infant recorded blood Hg 19 µg/L and urine Hg 274 µg/g. The authors cite this case as a motivating exposure pathway for the present study; the present study does not measure biomarkers in human subjects.
Methods
Sampling. Sixty skin-lightening products were purchased from twelve vendor locations across Jamaica between February and May 2017. The vendor survey approach paralleled the Zero Mercury Working Group brand-survey method (ref. 10 of the source). Sample selection prioritized the most popular products on the Jamaican retail market as identified by the user survey conducted in parallel. Product name, physical description, and label ingredient list were recorded for each. Product-form categories used downstream: creams, gels, lotions, and bar soaps.
XRF screening. All 60 products were screened on a Niton XL3T GOLDD+ portable handheld energy-dispersive X-ray fluorescence analyzer, using the instrument’s built-in “plastics mode” calibration. Approximately 10 mL of cream, gel, or lotion was placed in a sample cup and covered with Mylar film; bar soaps were cut to 5 g aliquots. Each sample was measured for one minute in triplicate. The analyzer’s stock manufactured calibrations do not include mercury in cream or soap matrices, so the team manually constructed a calibration curve by spiking a representative lotion matrix with mercury chloride standards at 20, 40, and 100 ppm Hg and measuring recovery (R² = 0.99 across the three spike points). Mean mercury recovery in the spiked-lotion matrix was approximately 65%. Using the manual calibration curve, the analyzer’s mercury detection limit in the cream/soap matrix was estimated at approximately 10 ppm. Accuracy was further verified against a multi-element reference material (Niton PN 180-554, batch SN PE-079-N, ThermoFisher Scientific): certified value 1002 ppm; measured value 969 ± 4.5 ppm.
CVAAS confirmatory analysis. Twenty-five of the 60 products whose XRF screens fell below the 10 ppm XRF detection limit were re-analyzed by cold-vapor atomic absorption spectroscopy on a Buck Scientific 400A mercury analyzer. Sample digestion used approximately 0.25 g of product treated with sulfuric acid and 1:1 perchloric and nitric acids; the digestate was diluted to 100 mL. A 50 mL aliquot was reduced with 5 mL of stannous chloride in a biological-oxygen-demand bottle attached to the aeration apparatus; maximum mercury absorbance was recorded at 2 minutes. Each batch included a blank, a standard, and spike samples. Working standards were prepared from a 1000 mg/L ascorbic-acid stock solution at two ranges: low (0.05–0.5 µg Hg/mL) and high (1.0–5.0 µg Hg/mL). CVAAS detection limit: 0.03 µg/g (≈30 ppb Hg).
Speciation. Both XRF and CVAAS measure total mercury. The study does not distinguish elemental, inorganic (Hg²⁺ salts), or organic (methylmercury) species. The authors’ introduction notes that inorganic mercury is the typical added ingredient in skin-lightening products (it inhibits melanin formation) but that methylmercury has also been reported. The mercury concentrations reported throughout this study are total Hg only.
User survey. A convenience sample of 384 self-identified users of skin-lightening products was recruited from the same Jamaican parishes covered by the vendor survey. Participants completed a self-administered questionnaire on product usage patterns, demographics, and self-reported health effects, with informed verbal consent. The instrument is reproduced in the source’s Supplemental Material 1.
Statistics. Data analysis used Microsoft Excel 2013 and SPSS version 17.
Implications
Certification. The paper contributes occurrence data for the skin-lightening cosmetic product class on the Jamaican market in 2017. Within the 60-product XRF panel, 6 of 60 products (10%) exceeded the US FDA 1 ppm cosmetic limit, and 3 of 60 products (5%) exceeded 400 ppm, with a single-sample maximum of 17,547 ppm (body text) — 17,345 ppm (Table 5 attribution) measured by XRF. Within the 25-product CVAAS sub-panel (which excludes the high-XRF tail by construction), 3 of 25 products (12%) exceeded the FDA 1 ppm cosmetic limit; the cream formulation carried the highest mean Hg concentration (0.67 ± 1.04 ppm, n=14) within the CVAAS sub-panel, with soap (0.18 ± 0.11, n=7), lotion (0.11 ± 0.01, n=2), and “other” (0.05 ± 0.01, n=2) lower. The full-panel XRF range spans five orders of magnitude (0.05–17,547 ppm), so a panel-level central-tendency statistic understates the upper-tail public-health signal that the three above-400 ppm products represent. (Routing of this source to the Advisory: Skin-Lightening Products slug and from there to the Advisory: Skin-Lightening Products public advisory rather than to a Cat 2 certification row reflects the HMTc Cat 2 Step 0 lock decision recorded in the linked reference record and is documented in the Verification notes below; that routing is governance state, not a claim of this paper.)
Courses. The two-stage analytical design (handheld XRF screening followed by CVAAS confirmation on the sub-detection-limit fraction) is a useful field-surveillance template for situations where the contamination distribution spans many orders of magnitude. The paper’s recovery experiment with HgCl₂ spikes of a lotion matrix at three concentrations (20, 40, 100 ppm) — yielding R² = 0.99 across the three points but only ~65% mean recovery — illustrates a common XRF cosmetic-matrix limitation that downstream courses can use as a worked example of calibration-versus-recovery distinctions.
App. The consumer app does not surface brand-level rankings. Skin-lightening products as a category should be flagged for mercury concern; the heterogeneity documented here (95% of products below 10 ppm but a 5% tail above 400 ppm, with the maximum at 17,547 ppm) means a category-level flag is the only defensible app behavior in the absence of per-product testing data.
Microbiome. Not addressed by this paper.
Related evidence
- Mercury, Total
- Mercury
- Children Personal Care (HMT&C Category 2 master)
- products/skin-lightening-lotion
- products/skin-lightening-soap
- regulations/fda-cosmetic-mercury-1ppm
Update history
No substantive edit history is available in this build. The full commit record is available in git.
